Shares of Hypermarcas (OTCMKTS:HYPMY – Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $4.10 and traded as high as $4.18. Hypermarcas shares last traded at $4.16, with a volume of 13,910 shares trading hands.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. Zacks Research upgraded Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Hypermarcas presently has a consensus rating of “Buy”.
Read Our Latest Report on HYPMY
Hypermarcas Stock Performance
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Further Reading
- Five stocks we like better than Hypermarcas
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
